AXT, Inc. (AXTI) is a Nasdaq-listed producer of compound semiconductor substrates — indium phosphide, gallium arsenide and germanium wafers — manufactured largely through its Beijing Tongmei subsidiary and sold to makers of optical transceivers, lasers and wireless devices. The stock traded at $36.89 on Monday, down 11.83% from Friday's close of $41.84, confirming a decisively lower session. There was no company press release, filing or analyst action behind the drop. Instead, the decline extended a violent de-rating of AI-infrastructure suppliers triggered by a sharply more cautious outlook for data-center capital spending.
The catalyst was a model update from semiconductor research firm SemiAnalysis, which cut its projections for AI accelerator shipments, capital expenditure, HBM demand and power requirements. The revisions were concentrated in 2028 through 2030, with global AI accelerator capex now projected at roughly $923 billion by 2030 versus a prior estimate of about $1.53 trillion — a reduction of more than $600 billion. For AXT, that matters directly: its indium phosphide wafers sit inside the 800G and 1.6T optical transceivers that connect GPU clusters, and management has anchored its growth story on hyperscaler optical build-outs. A lower long-range capex trajectory implies slower incremental demand for exactly the substrate capacity AXT is spending heavily to add.
The selling was indiscriminate across the photonics complex rather than specific to AXT. Lumentum (LITE), a customer that prepaid $43.5 million for wafers under a long-term supply agreement, fell roughly 8%, while Coherent (COHR) dropped more than 9%, Applied Optoelectronics (AAOI) lost about 7% and Ciena (CIEN) and Credo (CRDO) each shed 6% to 9%. When the entire optical supply chain trades as one basket, the highest-beta member absorbs an outsized share of the outflow — and AXTI, with a beta near 2.0, is that member.
AXT's Q3 results, reported October 29, were strong: revenue of $73.4 million rose 162% year over year, non-GAAP EPS of $0.41 beat by a wide margin, gross margin reached 56.1% and backlog topped $500 million. That is precisely why the sell-off is about multiple compression rather than fundamentals. At roughly $2.4 billion of market value, the stock trades near 90 times trailing earnings and about 21 times forward estimates — a premium that requires flawless execution on the 2027 capacity doubling. Add unresolved risk around Chinese export permits and Tongmei's planned Hong Kong listing, and investors have little cushion when the sector's growth narrative wobbles.
The move was aligned with, but larger than, the tape. The Nasdaq fell about 1.2% at the open, the S&P 500 lost roughly 0.8% and the Dow barely moved, while memory, server and semiconductor names fell 5% to 7%. Turnover in AXTI has been running far above normal, with roughly 13.5 million shares changing hands daily over the past ten sessions — heavy participation that amplifies directional moves. Technically, the stock has now broken below the $39–$40 shelf that held last week and sits about 74% beneath its 52-week high of $143.16, set in late May. It is down more than 55% since early October.
On a scale where 0 means no meaningful news and a normal move, and 100 means transformative news plus an extreme, rare price move, AXTI scores 21 out of 100. The verified news was sector-level, not company-level: a material cut to long-range AI capex forecasts, judged meaningful but indirect for a company of AXT's size. The price move was about 1.8 times the stock's typical daily swing of roughly 6.6% over the past 60 sessions, and moves of this magnitude occurred eight times in that window. A notable but far from unprecedented decline, paired with indirect news, produces a low score.
The fourth-quarter report, expected in mid-February, is the next hard datapoint. Management has guided to roughly $90 million in revenue, non-GAAP EPS of $0.57 to $0.59 and gross margin above 60%, and investors will want evidence that capacity additions are converting into shipments rather than inventory. Nvidia's (NVDA) earnings and Anthropic's market debut will shape the sector's risk appetite in the near term, while progress on Tongmei's Hong Kong listing and the pace of Chinese export permitting remain company-specific swing factors. The key uncertainty is whether AI optical demand keeps outrunning supply through 2027, or whether the more cautious capex view now circulating proves closer to reality.
Tickeron's Trending AI Robots page curates the strongest-performing automated strategies under current market conditions from a library of hundreds of AI trading bots spanning thousands of tickers. Because bots differ widely in strategy logic, holding period, risk profile and the symbols they trade, the featured selection rotates as market conditions change. Reviewing that shortlist is a practical way to see which approaches are working right now — and to compare them against your own research before making any decision.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for AXTI moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 29 of the 34 cases the stock moved higher. This puts the odds of a move higher at 85%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 55 cases where AXTI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
Following a +16.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in 217 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
AXTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXTI as a result. In 71 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for AXTI turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 36 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
AXTI moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AXTI crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
The 50-day moving average for AXTI moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for AXTI entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.885) is normal, around the industry mean (5.670). AXTI's P/E Ratio (1296.000) is considerably higher than the industry average of (68.795). AXTI's Projected Growth (PEG Ratio) (0.100) is slightly lower than the industry average of (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (26.596) is also within normal values, averaging (27.897).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufactures of high-performance compound semiconductor substrates
Industry ElectronicProductionEquipment